adjust model potenti coronaviru impact
quick read challeng persist hexo liquid remain
risk
analyst certif import disclosur see
ahead demand updat across coverag earn season previous lower estim across
coverag sector note focu company-specif notabl facts/assumpt around financi posit product
statu end market exposur particular note tel balanc sheet strong end debt/ebitda
net cash hand coven outstand debt credit facil coven breach higher
four consecut quarter revolv credit facil undrawn anticip near-term use earli februari
tel issu senior note earmark june debt matur materi matur
first sensor acquisit matur approxim
adjust model potenti coronaviru impact
earlier today re-affirmed guidanc compani note seen signific declin retail
sale last two week updat forecast build impact relat coronaviru
assumpt assum declin jun sale improv decreas sep sale growth rate
exclud retail like remain extra-cauti even follow coronaviru place re-ord preserv
cash coronaviru believ remain insul like retail turmoil given compani exposur potenti
retail winner includ liquid remain adequ manag coronaviru crisi
quick read challeng persist hexo liquid remain risk
earlier morn hexo report anoth challeng quarter top-lin result match pre-announc
compani report adjust ebitda loss even exclud item inventori impair
although industri backdrop remain challeng expens control gross margin move
right direct manag continu see path posit ebitda near-term hexo also estim requir
addit capit order meet oblig commit budget expenditur januari
remain sidelin entir cannabi coverag continu view space highli specul
tsa checkpoint number deceler pt y/i last seven day vs total
travel throughput y/i vs respect show outsiz impact
travel industri take optimist viewpoint us citizen compani proactiv
restrict travel flatten curv
mdwd announc suspens escharex phase ii enrol due importantli manag
reiter bla file nexobrid continu plan forecast juli unchang continu view us approv
launch nexobrid partner primari near-term opportun valu creation furthermor
nexobrid expand access protocol continu enrol patient mdwd manufactur facil continu oper
adequ suppli least next sever quarter last manag note full-year procur guidanc barda
unchang time deliveri may impact revis forecast timelin time bias
toward larger portion annual barda procur slip interim updat escharex phase ii studi
slip end await detail updat manag reivis outlook
